Location: New York, NY
CIK: 0001952142 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value: $312M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,372,634 | $22.22M | 7.1% | $15.22 | -27.7% | COM | 87164F105 |
| IMVT | IMMUNOVANT INC | 1,300,860 | $20.81M | 6.7% | $25.84 | -41.5% | COM | 45258J102 |
| SRRK | SCHOLAR ROCK HLDG CORP | 528,115 | $18.71M | 6.0% | $36.74 | -14.6% | COM | 80706P103 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,265,672 | $16.63M | 5.3% | $14.79 | — | SPONSORED ADS | 152309100 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 52,694 | $15.95M | 5.1% | $321.75 | -7.4% | COM | 558868105 |
| — | MERUS N V | 266,094 | $14M | 4.5% | $39.75 | — | COM | N5749R100 |
| ACLX | ARCELLX INC | 201,452 | $13.27M | 4.3% | $67.74 | -8.1% | COMMON STOCK | 03940C100 |
| — | CIDARA THERAPEUTICS INC | 266,774 | $12.99M | 4.2% | $48.71 | — | COM NEW | 171757206 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 176,752 | $11.17M | 3.6% | $59.81 | +2.4% | COM | 76243J105 |
| ALKS | ALKERMES PLC | 351,124 | $10.04M | 3.2% | $29.07 | +2.4% | SHS | G01767105 |
| DNLI | DENALI THERAPEUTICS INC | 707,915 | $9.904M | 3.2% | $21.88 | -35.7% | COM | 24823R105 |
| LEGN | LEGEND BIOTECH CORP | 270,144 | $9.587M | 3.1% | $35.49 | — | SPONSORED ADS | 52490G102 |
| GERN | GERON CORP | 6,649,244 | $9.375M | 3.0% | $1.56 | -9.4% | COM | 374163103 |
| ZLAB | ZAI LAB LTD | 250,438 | $8.758M | 2.8% | $35.09 | — | ADR | 98887Q104 |
| MLYS | MINERALYS THERAPEUTICS INC | 631,586 | $8.551M | 2.7% | $14.49 | 0.0% | COM | 603170101 |
| QURE | UNIQURE NV | 572,615 | $7.982M | 2.6% | $13.36 | +0.7% | SHS | N90064101 |
| ROIV | ROIVANT SCIENCES LTD | 601,781 | $6.782M | 2.2% | $10.18 | +6.5% | SHS | G76279101 |
| — | AKERO THERAPEUTICS INC | 116,779 | $6.231M | 2.0% | $40.48 | — | COM | 00973Y108 |
| INSM | INSMED INC | 61,578 | $6.197M | 2.0% | $72.02 | +6.2% | COM PAR $.01 | 457669307 |
| SRZN | SURROZEN INC | 686,539 | $6.138M | 2.0% | $9.54 | -4.2% | COM NEW | 86889P208 |
| WVE | WAVE LIFE SCIENCES LTD | 900,338 | $5.852M | 1.9% | $6.97 | -5.3% | SHS | Y95308105 |
| LENZ | LENZ THERAPEUTICS INC | 183,912 | $5.39M | 1.7% | $27.20 | 0.0% | COM | 52635N103 |
| NUVL | NUVALENT INC | 59,828 | $4.565M | 1.5% | $89.78 | -18.5% | COM | 670703107 |
| KALV | KALVISTA PHARMACEUTICALS INC | 386,790 | $4.373M | 1.4% | $10.36 | +18.0% | COM | 483497103 |
| VTGN | VISTAGEN THERAPEUTICS INC | 2,413,254 | $4.117M | 1.3% | $3.57 | -36.4% | COM | 92840H400 |
| APGE | APOGEE THERAPEUTICS INC | 84,466 | $3.668M | 1.2% | $38.04 | 0.0% | COM | 03770N101 |
| IDYA | IDEAYA BIOSCIENCES INC | 165,885 | $3.487M | 1.1% | $20.04 | -4.3% | COM | 45166A102 |
| TARA | PROTARA THERAPEUTICS INC | 1,143,677 | $3.465M | 1.1% | $4.05 | -14.8% | COM STK | 74365U107 |
| BBOT | HELIX ACQUISITION CORP II | 315,812 | $3.291M | 1.1% | $10.52 | +2.8% | CL A ORD SHS | G4444H101 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 329,254 | $3.098M | 1.0% | $6.91 | 0.0% | COM NEW | 30233G209 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 205,672 | $2.884M | 0.9% | $5.99 | +134.2% | COM | 03969K108 |
| RZLT | REZOLUTE INC | 644,654 | $2.875M | 0.9% | $3.71 | 0.0% | COM NEW | 76200L309 |
| TSHA | TAYSHA GENE THERAPIES INC | 1,203,941 | $2.781M | 0.9% | $2.17 | 0.0% | COM SHS | 877619106 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 152,652 | $2.765M | 0.9% | $20.97 | -13.0% | ORDINARY SHARES | N62509109 |
| BHVN | BIOHAVEN LTD | 174,754 | $2.466M | 0.8% | $36.20 | -50.8% | COM | G1110E107 |
| REGN | REGENERON PHARMACEUTICALS | 4,672 | $2.453M | 0.8% | $556.12 | 0.0% | COM | 75886F107 |
| BBIO | BRIDGEBIO PHARMA INC | 54,630 | $2.359M | 0.8% | $33.72 | +7.9% | COM | 10806X102 |
| JANX | JANUX THERAPEUTICS INC | 89,933 | $2.077M | 0.7% | $39.68 | -33.6% | COM | 47103J105 |
| ORIC | ORIC PHARMACEUTICALS INC | 200,785 | $2.038M | 0.7% | $6.71 | 0.0% | COM | 68622P109 |
| MBX | MBX BIOSCIENCES INC | 141,021 | $1.609M | 0.5% | $10.45 | -2.5% | COM | 55287L101 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 150,000 | $1.593M | 0.5% | $10.07 | +3.8% | CL A ORD SHS | G70077105 |
| PRAX | PRAXIS PRECISION MEDICINES I | 32,255 | $1.356M | 0.4% | $38.08 | 0.0% | COM NEW | 74006W207 |
| GHRS | GH RESEARCH PLC | 100,826 | $1.229M | 0.4% | $10.96 | 0.0% | ORDINARY SHARES | G3855L106 |
| TNGX | TANGO THERAPEUTICS INC | 208,800 | $1.069M | 0.3% | $2.47 | 0.0% | COM | 87583X109 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 16,770 | $927K | 0.3% | $43.60 | +10.1% | COM | 74366E102 |
| TECX | TECTONIC THERAPEUTIC INC | 40,000 | $795K | 0.3% | $20.27 | 0.0% | COM | 878972108 |
| ADCT | ADC THERAPEUTICS SA | 283,286 | $759K | 0.2% | $2.10 | 0.0% | SHS | H0036K147 |
| — | VERONA PHARMA PLC | 7,407 | $701K | 0.2% | $94.58 | — | SPONSORED ADS | 925050106 |
| ABVX | ABIVAX SA | 87,748 | $671K | 0.2% | $7.65 | — | SPONSORED ADS | 00370M103 |
| ROIV | ROIVANT SCIENCES LTD | 915,000 | $618K | 0.2% | $10.18 | +6.5% | Call | G76279101 |
| — | MIND MEDICINE MINDMED INC | 90,852 | $590K | 0.2% | $6.49 | — | COM NEW | 60255C885 |
| IMVT | IMMUNOVANT INC | 100,000 | $310K | 0.1% | $25.84 | -41.5% | Call | 45258J102 |
| GERN | GERON CORP | 300,000 | $52,500 | 0.0% | $1.56 | -9.4% | Call | 374163103 |